BAY 1000394
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 1000394, covering 2016-07-01 to 2016-07-01. Get the full timeline:
Most recent: Clinical Trial Update: BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors [Phase 2]